Company Overview
HCA Healthcare, Inc. functions as a comprehensive provider of health care services across the United States, owning, managing, and operating a diverse portfolio that includes hospitals, ambulatory surgery centers, freestanding emergency care facilities, urgent care centers, walk-in clinics, and diagnostic and imaging centers. The company operates within the Healthcare sector and specifically within the Medical Care Facilities industry, positioning it as a central entity in the delivery of acute and specialized medical care. This massive scale is evidenced by a market capitalization of $105.52B and annual revenue reaching $75.60B, supported by a workforce of 230,000 employees. These valuation and revenue figures indicate that HCA holds a substantial position in the market, reflecting the significant economic footprint and operational dominance required to manage such a vast network of facilities nationwide.
Financial Health
The company reported revenue of $75.60B and generated a net income of $6.78B, while EBITDA stood at $15.49B, revealing a cost structure where operating expenses and taxes consume a significant portion of top-line revenue before reaching the bottom line. The gap between the $75.60B revenue and $6.78B net income highlights the substantial fixed costs associated with running hospitals and clinics, as well as the impact of tax obligations and interest payments on the overall profitability. Free cash flow amounted to $5.82B, which provides the organization with significant financial flexibility to fund capital expenditures, manage debt obligations, or pursue strategic acquisitions without relying solely on external financing. Analyzing the margins reveals a gross margin of 41.5%, indicating the efficiency of revenue generation relative to the direct cost of goods sold in a labor-intensive service environment. The operating margin sits at 16.3%, reflecting the effectiveness of internal management and overhead control, while the profit margin of 9.0% demonstrates the final return after all expenses, interest, and taxes are deducted. When comparing total cash of $1.14B against total debt of $48.70B, the balance sheet appears leveraged, a common characteristic for capital-intensive healthcare operators who utilize debt to finance infrastructure expansion. The debt-to-equity ratio is listed as N/A in the available data, so specific leverage ratios derived from equity are not disclosed in the provided metrics. The current ratio stands at 0.96, indicating that current assets are slightly below current liabilities, which suggests a tight short-term liquidity position that requires careful management of working capital to meet immediate obligations. Return on Assets is reported at 12.4%, showing that the company generates a robust return relative to its total asset base, while Return on Equity is listed as N/A, preventing a direct assessment of shareholder yield efficiency from the provided figures.
Valuation Assessment
The trailing twelve-month P/E ratio is 16.67, whereas the forward P/E is projected at 14.18, implying that the market expects earnings to grow sufficiently in the future to justify a lower multiple on expected versus historical earnings. The price-to-book ratio is reported as -17.58, a negative figure that often arises in capital-intensive industries where accumulated depreciation reduces the book value of assets below the market price, complicating the interpretation of a traditional premium over book value. Alternative valuation metrics such as the price-to-sales ratio of 1.40 and an EV/EBITDA of 10.09 provide context on the company's valuation relative to its sales volume and operating earnings, suggesting a moderate multiple compared to high-growth tech sectors but typical for mature healthcare services. The stock has traded between a 52-week low of $314.43 and a 52-week high of $556.52, placing the current trading range within a wide band that reflects significant market volatility over the past year. The beta value of 1.34 indicates that the stock is more volatile than the broader market, meaning it is expected to experience larger price swings in both upward and downward directions relative to the overall market index.
Growth & Income
Revenue growth year-over-year is recorded at 6.7%, while earnings growth is significantly higher at 44.5%, implying that the company is leveraging its scale and operational leverage to increase profitability at a pace much faster than its top-line expansion. This divergence suggests that cost efficiencies or mix shifts are driving earnings disproportionately higher than simple volume growth in the revenue stream. As a dividend payer, HCA offers a dividend yield of 0.7% with a payout ratio of 10.2%, indicating that the company retains the vast majority of its earnings for reinvestment rather than distributing them to shareholders. Such a low payout ratio is sustainable given the strong earnings growth and suggests a conservative approach to dividends that prioritizes balance sheet strength and future expansion over immediate shareholder income. The overall growth and income profile reflects a mature, large-cap operator delivering double-digit earnings growth on a modest dividend yield, characteristic of the healthcare services sector where capital expenditure and debt servicing often limit dividend growth rates.